Clinical Trials Directory

Trials / Completed

CompletedNCT02906137

Gut-Associated Lymphocyte Trafficking

Altered Homing of T Lymphocytes to the Gut and Poor Immune Reconstitution of the Intestinal Mucosa in Treated HIV-infected Individuals

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
ANRS, Emerging Infectious Diseases · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The gut immune barrier is not fully restored in HIV-1-infected subjects despite they were receiving antiretroviral treatment. This leaky gut leads to microbial translocation from the gut lumen into the bloodstream that fuels deleterious systemic inflammation. The chemotaxis axes that allow T lymphocytes to migrate from the blood to the gut mucosa in order to reconstitute the mucosal immune barrier seems altered in treated HIV-1-infected subjects.This study aims at better understanding the mechanisms involved in this lack of mucosal immune restoration.

Detailed description

Pathophysiological study in human subjects, comparative, national, multicentric and prospective. Peripheral blood and intestinal biopsies will be collected.

Conditions

Interventions

TypeNameDescription
OTHERPeripheral blood and intestinal biopsies will be collectedBlood draw and intestinal biopsies

Timeline

Start date
2017-02-06
Primary completion
2020-02-25
Completion
2020-02-25
First posted
2016-09-19
Last updated
2022-01-14

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02906137. Inclusion in this directory is not an endorsement.